pdp-Amlodipine (amlodipine)

pCPA File Number: 21916

Negotiation Status:

Concluded with an LOI

Indication(s):

Mild to moderate essential hypertension and management of chronic stable angina

Sponsor/Manufacturer:

Pendopharm, a division of Pharmascience Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-07-18

Negotiation Process Concluded:

2022-11-14